Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy ABVC Biopharma stock

Learn how to easily invest in ABVC Biopharma stock.

California biopharmaceutical company ABVC Biopharma, a company focused on drug and medical device development, is expected to conduct a public offering of units comprised of one share of common stock and one series A warrant each. The company, which is currently listed on the Over-the-Counter Markets under the ticker symbol "ABVC," has applied for listing on the Nasdaq. The offering of units is contingent upon Nasdaq approving this listing. If approved, ABVC's stock will trade under the ticker symbol "ABVC."

How to buy shares in ABVC Biopharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ABVC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

ABVC Biopharma stock price (NASDAQ: ABVC)

Use our graph to track the performance of ABVC stocks over time.

ABVC Biopharma shares at a glance

Information last updated 2022-09-25.
Latest market close$0.88
52-week range$0.50 - $6.03
50-day moving average $0.82
200-day moving average $2.00
Wall St. target price$3.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.67

Buy ABVC Biopharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ABVC Biopharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ABVC Biopharma price performance over time

Historical closes compared with the close of $0.88 from 2022-09-30

1 week (2022-09-23) -3.67%
1 month (2022-09-02) -13.73%
3 months (2022-07-01) -12.87%
6 months (2022-03-30) -68.90%
1 year (2021-09-28) N/A
2 years (2020-10-02) -78.54%
3 years (2019-10-02) 7.18
5 years (2017-09-28) N/A

ABVC Biopharma financials

Revenue TTM $399,726
Gross profit TTM $350,711
Return on assets TTM -91.76%
Return on equity TTM -346.98%
Profit margin 0%
Book value $0.29
Market capitalisation $29.8 million

TTM: trailing 12 months

ABVC Biopharma share dividends

We're not expecting ABVC Biopharma to pay a dividend over the next 12 months.

You may also wish to consider:

Have ABVC Biopharma's shares ever split?

ABVC Biopharma's shares were split on a 1:18 basis on 8 May 2019. So if you had owned 18 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ABVC Biopharma shares – just the quantity. However, indirectly, the new 1700% higher share price could have impacted the market appetite for ABVC Biopharma shares which in turn could have impacted ABVC Biopharma's share price.

ABVC Biopharma share price volatility

Over the last 12 months, ABVC Biopharma's shares have ranged in value from as little as $0.5 up to $6.03. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ABVC Biopharma's is 0.3036. This would suggest that ABVC Biopharma's shares are less volatile than average (for this exchange).

To put ABVC Biopharma's beta into context you can compare it against those of similar companies.

ABVC Biopharma overview

ABVC BioPharma, Inc. , a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.

Frequently asked questions

What percentage of ABVC Biopharma is owned by insiders or institutions?
Currently 40.302% of ABVC Biopharma shares are held by insiders and 4.789% by institutions.
How many people work for ABVC Biopharma?
Latest data suggests 28 work at ABVC Biopharma.
When does the fiscal year end for ABVC Biopharma?
ABVC Biopharma's fiscal year ends in December.
Where is ABVC Biopharma based?
ABVC Biopharma's address is: 44370 Old Warm Springs Boulevard, Fremont, CA, United States, 94538
What is ABVC Biopharma's ISIN number?
ABVC Biopharma's international securities identification number is: US00091F1066

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site